Fundraising FoxCentral Texas Angel Network — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Pixion develops a patented dry electrode processing technology for lithium-ion battery production, aimed at lowering costs, reducing factory footprints, and improving cell performance.
CleantechEnergyNew MaterialsAustin, US
Vikram Devaraj(Executive Officer, Director)Varun Devaraj(Executive Officer, Director)
BoardWilliam Clark(Director)
Co-investorsSymbiotic Ventures
Rebel Medicine develops preclinical investigational drugs and wound care products designed to provide pain relief without opioids.
BiotechHealthtechMedical DevicesSalt Lake City, US
Brett Davis(Executive Officer, Director)inCaleb Lade(Executive Officer, Director)
BoardJohn Poyhonen(Director)Kevin Passey(Director)Mai Nguyen(Director)
Co-investorsColorado BioScience AssociationUtah Innovation Fund
SpayVac develops a single-dose vaccine platform for fertility management in production animals, including applications for boar taint prevention in swine, population control in bison, and sterility in farmed fish.
AgTechBiotechHealthtechImpact & Social GoodMadison, US
Thomas D'Orazio(Executive Officer, Director)inMark Fraker(VP – Operations)inUrsula Bechert(VP – Research & Development)inTom(CEO)Tina(Chief Operating Officer)in
BoardJeffrey Rusinow(Director)
Co-investorsSymbiotic VenturesSerra Ventures
VISIE develops computer vision systems for surgical robotics that enable real-time visual tracking of patient anatomy without requiring reference pins or arrays.
AI & Machine LearningDeep TechHardwareMedical DevicesRoboticsAustin, US
Aaron Bernstein(Executive Officer, Director)inDoug Fairbanks(CEO)in
BoardJonathan Black(Director)Lon White(Director)Addie Harris(Director)
Co-investorsCartmell Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.